<?xml version="1.0" encoding="UTF-8"?>
<p>Positive results for AHCC were also obtained in a clinical study conducted with patients suffering from epithelial ovarian cancer or peritoneal cancer undergoing platinum-based chemotherapy [
 <xref rid="B94-ijms-22-00634" ref-type="bibr">94</xref>]. An intake of 3 g/d (500mg/capsule) throughout six cycles of chemotherapeutic treatment resulted in increased levels of CD8+T cell lymphocytes, and in reduced side effects, such as nausea and vomiting. However, increased muscle pain was noted.
</p>
